The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 6720-6732

  Stüve, Olaf ^a   Youssef, Sawsan ^c   Slavin, Anthony J ^d   King, Chelsea L ^a   Patarroyo, Juan Carlos ^a   Hirschberg, David L ^c   Brickey, W June ^e   Soos, Jeanne M ^f   Piskurich, Janet F ^g   Chapman, Harold A ^b   Zamvil, Scott S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d AMGEN INC   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f GLAXOSMITHKLINE   (United States)

^g MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BRAIN ANTIGEN; CATHEPSIN S; CYTOKINE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; EPITOPE; H2 M ANTIGENS; H2-M ANTIGENS; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MHC CLASS II TRANSACTIVATOR PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN 1 11; MYELIN BASIC PROTEIN 1-11; NUCLEAR PROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TH1 CELL; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; ENDOCYTOSIS; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; INVARIANT CHAIN; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ASTROCYTES; CELL LINE, TRANSFORMED; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOCYTOSIS; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, NATURAL; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTE SUBSETS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0037114162     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.6720     Document Type: Article

References (71)

1. Martin, R., H. F. McFarland, and D, E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
2. Zamvil, S. S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579.
3. Wekerle, H., C. Linington, H. Lassmann, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trends Neurosci. 9:271.
4. Hickey, W. F., B. L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254.
5. Slavin, A. J., J. M. Soos, O. Stuve, J. C. Patarroyo, H. L. Weiner, A. Fontana, E. K. Bikoff, and S. S. Zamvil. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108:1133.
6. Flugel, A., T. Berkowicz, T. Ritter, M. Labeur, D, E. Jenne, Z. Li, J. W. Ellwart, M. Willem, H. Lassmann, and H. Wekerle. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547.
7. Krakowski, M., and T. Owens. 2000. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur. J. Immunol. 30:1002.
8. Fontana, A., W. Fierz, and H. Wekerle. 1984. Astrocytes present myclin basic protein to encephalitogenic T-cell lines. Nature 307:273.
9. Shrikant, P., and E. N. Benveniste. 1996. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J. Immunol. 157:1819.
10. Aloisi, F., F. Ria, G. Penna, and L. Adorini. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:4671.
11. Weber, F., E. Meinl, F. Aloisi, C. Nevinny-Stickel, E. Albert, H. Wekerle, and R. Hohlfeld. 1994. Human astrocytes are only partially competent antigen presenting cells. I. Possible implications for lesion development in multiple sclerosis. Brain 117:59.
12. + T cell responses in the central nervous system. J. Exp. Med. 173:1235.
13. Takiguchi, M., and J. A. Frelinger. 1986. Induction of antigen presentation ability in purified cultures of astroglia by interferon-γ. J. Mol. Cell. Immunol. 2:269.
14. Frei, K., H. Lins, C. Schwerdel, and A. Fontana. 1994. Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:2720.
15. Cornet, A., E. Bettelli, M. Oukka, C. Cambouris, V. Avellana-Adalid, K. Kosmatopoulos, and R. S. Liblau. 2000. Role of astrocytes in antigen presentation and naive T-cell activation. J. Neuroimmunol. 106:69.
16. Traugott, U., L. C. Scheinber, and C. S. Raine. 1985. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J. Neuroimmunol. 8:1.
17. Krogsgaard, M., K. W. Wucherpfennig, B. Canella, B. E. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C. Raine, J. Engberg, and L. Fugger. 2000. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191:1395.
18. Sakai, K., T. Tabira, M. Endoh, and L. Steinman. 1986. Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice. Lab. Invest. 54:345.
19. Traugott, U. 1989. Detailed analysis of early immunopathologic events during lesion formation in acute experimental autoimmune encephalomyelitis. Cell. Immunol. 119:114.
20. Soos, J. M., J. Morrow, T. A. Ashley, B. E. Szente, E. K. Bikoff, and S. S. Zamvit. 1998. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol. 161:5959.
21. Tan, L., K. B. Gordon, J. P. Mueller, L. A. Matis, and S. D. Miller. 1998. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J. Immunol. 160:4271.
22. Nikcevich, K. M., J. F. Piskurich, R. P. Hellendall, Y. Wang, and J. P. Ting. 1999. Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α. J. Neuroimmunol. 99:195.
23. Dong, Y., W. M. Rohn, and E. N. Benveniste. 1999. IFN-γ regulation of the type IV class II transactivator promoter in astrocytes. J. Immunol. 162:4731.
24. Suter, T., U. Malipiero, L. Otten, B. Ludewig, A. Muelethaler-Mottet, B. Mach, W. Reith, and A. Fontana. 2000. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur. J. Immunol. 30:794.
25. Mach. B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
26. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.
27. Waldburger, J. M., T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2001. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J. Exp. Med. 194:393.
28. Youssef, S., O. Stuve, J. C. Patarroyo, P. J. Ruiz, J. L. Radosevich, E. M. Hur, M. Bravo, D. J. Mitchell, R. A. Sobel, L. Steinman, and S. S. Zamvil. 2002. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420:78.
29. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
30. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
31. Gobin, S. J., A. Peijnenburg, V. Keijsers, and P. J. Van den Elsen. 1997. Site α is crucial for two routes of IFN γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601.
32. 2-microglobulin genes. Immunity 9:531.
33. Brenner, M., W. C. Kisseberth, Y. Su, F. Besnard, and A. Messing. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14:1030.
34. Brenner, M., and A. Messing. 1996. GFAP transgenic mice. Methods 10:351.
35. Mucke, L., M. B. Oldstone, J. C. Morris, and M. I. Nerenberg. 1991. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 3:465.
36. Pagenstecher, A., S. Lassmann, M. J. Carson, C. L. Kincaid, A. K. Stalder, and I. L. Campbell. 2002. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. J. Immunol. 164:4481.
37. Liuzzo, J. P., S. S. Petanceska, and L. A. Devi. 1999. Neurotrophic factors regulate cathepsin S in macrophages and microglia: a role in the degradation of myelin basic protein and amyloid β peptide. Mol. Med. 5:334.
38. Smith, M. E. 1969. An in vitro system for the study of myelin synthesis. J. Neurochem. 16:83.
39. Itoh-Lindstrom, Y., J. F. Piskurich, N. J. Felix, Y. Wang, W. J. Brickey, J. L. Platt, B. H. Koller, and J. P. Ting. 1999. Reduced IL-4-, lipopolysaccharide-, and IFN-γ-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 163:2425.
40. Zamvil, S. S., D. J. Mitchell, A. C. Moore, K. Kitamura, L. Steinman, and J. B. Rothbard. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
41. Sims, T. N., J. F. Elliott, V. Ramassar, D. W. Denney Jr., and P. F. Halloran. 1997. Mouse class II transactivator: cDNA sequence and amino acid comparison with the human Class II transactivator. Immunogenetics 45:220.
42. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (li): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6:1677.
43. Cho, S., M. Attaya, M. G. Brown, and J. J. Monaco. 1991. A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex. Proc. Natl. Acad. Sci USA 88:5197.
44. +-Cl-cotransporter (NKCCI) in asthmatic subjects. Genome Res. 11:1473.
45. Oi, V. T., P. P. Jones, J. W. Goding, L. A. Herzenberg, and L. A. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115.
46. Williams, G. S., M. Malin, D. Vremec, C. H. Chang, R. Boyd, C. Benoist, and D. Mathis. 1998. Mice lacking the transcription factor CIITA-a second look. Int. Immunol. 10:1957.
47. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
48. Martin, B. K., K. C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591.
49. + T cells in a model for multiple sclerosis. J. Exp. Med. 194:669.
50. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579.
51. Soos, J. M., T. A. Ashley, J. Morrow, J. C. Patarroyo, B. E. Szente, and S. S. Zamvil. 1999. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production. Int. Immunol. 11:1169.
52. Gresser, O., E. Weber, A. Hellwig, S. Riese, and A. Regnier-Vigouroux. 2001. Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S: Eur. J. Immunol. 31:1813.
53. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadangos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4:357.
54. Villadangos, J. A., and H. L. Ploegh. 2000. Proteolysis in MHC class II antigen presentation: who's in charge? Immunity. 12:233.
55. Siegrist, C. A., E. Martinez-Soria, I. Kern, and B. Mach. 1995. A novel antigenprocessing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-γ. J. Exp. Med. 182:1793.
56. Chang, C. H., S. C. Hong, C. C. Hughes, C. A. Janeway Jr., and R. A. Flavell. 1995. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7:1515.
57. Armstrong, T. D., V. K, Clements, B. K. Martin, J. P. Ting, and S. Ostrand-Rosenberg. 1997. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci USA 94:6886.
58. Hershberg, R. M., D. H. Cho, A. Youakim, M. B. Bradley, J. S. Lee, P. E. Framson, and G. T. Nepom. 1998. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J. Clin. Invest. 102:792.
59. Sartoris, S., M. T. Valle, A. L. Barbaro, G. Tosi, T. Cestari, A. D'Agostino, A. M. Megiovanni, F. Manca, and R. S. Accolla. 1998. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. J. Immunol 161:814.
60. Peijnenburg, A., S. J. Gobin, M. C. van Eggermond, B. C. Godthelp, N. van Graafeiland, and P. J. Van den Elsen. 1997. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression. J. Immunol. 159:2720.
61. Gourley, T., S. Roys, N. W. Lukacs, S. L. Kunkel, R. A. Flavell, and C. H. Chang. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity. 10:377.
62. Beek, H., G. Schwarz, C. J. Schroter, M. Deeg, D. Baier, S. Stevanovic, E. Weber, C. Driessen, and H. Kalbacher. 2001. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur. J. Immunol. 31:3726.
63. Nikcevich, K. M., K. B. Gordon, L. Tan, S. D. Hurst, J. F. Kroepfl, M. Gardiner, T. A. Barrett, and S. D. Miller. 1997. IFN-γ activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:614.
64. Dey, A., A. M. Thornton, M. Lonergan, S. M. Weissman, J. W. Chamberlain, and K. Ozato. 1992. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell. Biol. 12:3590.
65. Traugott, U., E. L. Reinherz, and C. S. Raine. 1983. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308.
66. Traugott, U., D. E. McFarlin, and C. S. Raine. 1986. Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell. Immunol. 99:395.
67. Chung, I. Y., J. G. Norris, and E. N. Benveniste. 1991. Differential tumor necrosis factor α expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173:801.
68. Campbell, I. L., C. R. Abraham, E. Masliah, P. Kemper, J. D. Inglis, M. B. Oldstone, and L. Mucke. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90:10061.
69. Lassmann, S., C. Kincaid, V. C. Asensio, and I. L. Campbell. 2001. Induction of type I immune pathology in the brain following immunization without central nervous system autoantigen in transgenic mice with astrocyte-targeted expression of IL-12. J. Immunol. 167:5485.
70. Meinl, E., F. Aloisi, B. Ertl, F. Weber, M. R. de Waal, H. Wekerle, and R. Hohlfeld. 1994. Multiple sclerosis. VI. Immunomodulatory effects of human astrocytes on T cells. Brain 117:1323.
71. Tompkins, S. M., J. Padilla, M. C. Dal Canto, J. P.-Y. Ting, L. Van Kaer, and S. D. Miller. 2002. De novo CNS processing of myelin antigen is required for the initiation of EAE. J. Immunol. 168:4173.